Cardiac connections - The antiarrhythmic solution?

New England Journal of Medicine

Volumn 358, Issue 13, 2008, Pages 1397-

  Duffy, Heather S ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAP JUNCTION PROTEIN; CONNEXIN 43;

ARRHYTHMOGENESIS; ARTICLE; CELL THERAPY; CELL TYPE; ELECTRIC CURRENT; EMBRYONIC STEM CELL; ENGRAFTMENT; HEART ARRHYTHMIA; HEART INFARCTION; HEART INJURY; HEART MUSCLE CELL; HUMAN; LIPID MEMBRANE; MESENCHYMAL STEM CELL; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CELL JUNCTION; CYTOLOGY; EMBRYO (ANATOMY); METABOLISM; MOUSE; TRANSPLANTATION;

ANIMALS; ARRHYTHMIAS, CARDIAC; CONNEXIN 43; EMBRYO, MAMMALIAN; GAP JUNCTIONS; HUMANS; MICE; MYOBLASTS, SKELETAL; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC;

EID: 41449104964     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcibr0708922     Document Type: Article

References (5)

1. Murry CE, Reinecke H, Pabon LM. Regeneration gaps: observations on stem cells and cardiac repair. J Am Coll Cardiol 2006;47:1777-85.
2. Mills WR, Mal N, Kiedrowski MJ, et al. Stem cell therapy enhances electrical viability in myocardial infarction. J Mol Cell Cardiol 2007;42:304-14.
3. Rosen MR. Are stem cells drugs? The regulation of stem cell research and development. Circulation 2006;114:1992-2000.
4. Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol 2005;23:845-56.
5. Roell W, Lewalter T, Sasse P, et al. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 2007;450:819-24.